Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026)
Bausch Health Companies (BHC) reported Free Cash Flow of $121.0 million for Q1 2026, up 26.04% on a YoY basis from $96.0 million in Q1 2025, and down 69.98% sequentially from $403.0 million in Q4 2025.
Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Free Cash Flow data on file, last reported at $121.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 26.04% year-over-year to $121.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (down 16.22% YoY), and the FY2025 full-year result was $1.0 billion, down 20.4% from the prior year.
- Free Cash Flow fell to $121.0 million in Q1 2026, from $403.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $495.0 million in Q4 2024 to a low of -$1.3 billion in Q3 2022.
- A 5-year average of $132.6 million and a median of $190.0 million in 2025 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 857.41% in 2022, while the deepest fall reached 362.87% in 2022.
- Tracing BHC's Free Cash Flow over 5 years: stood at $409.0 million in 2022, then retreated by 28.61% to $292.0 million in 2023, then jumped by 69.52% to $495.0 million in 2024, then fell by 18.59% to $403.0 million in 2025, then slumped by 69.98% to $121.0 million in 2026.
- Business Quant data shows BHC's Free Cash Flow at $121.0 million in Q1 2026, $403.0 million in Q4 2025, and $314.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 121.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.00 Mn |
| Mar 31, 2026 | 121.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Dec 31, 2023 | 292.00 Mn |
| Dec 31, 2023 | 292.00 Mn |